Financial Summary (All financials)
| In millions, except per share items | Jan-28-23 | Jan-29-22 | Jan-30-21 | Feb-01-20 |
| Revenues | 5,919.6 | 4,462.4 | 2,968.9 | 2,699.2 |
| Revenue growth | 32.7% | 50.3% | 10.0% | |
| Cost of goods sold | 2,932.1 | 2,398.2 | 1,480.6 | 1,342.2 |
| Gross profit | 2,987.5 | 2,064.2 | 1,488.3 | 1,356.9 |
| Gross margin | 50.5% | 46.3% | 50.1% | 50.3% |
| Sales and marketing | 843.6 | 955.3 | 467.2 | 464.6 |
| Research and development | 1,784.3 | 1,424.2 | 1,072.7 | 1,080.4 |
| EBITA | 1,425.4 | 631.7 | 221.2 | 124.7 |
| EBITA margin | 24.1% | 14.2% | 7.5% | 4.6% |
| Amortization of intangibles | 1,087.4 | 979.4 | 443.6 | 368.1 |
| EBIT | 338.0 | -347.7 | -222.4 | -243.4 |
| EBIT margin | 5.7% | -7.8% | -7.5% | -9.0% |
| Pre-tax income | 85.1 | -483.5 | -322.2 | 798.4 |
| Income taxes | 248.6 | -62.5 | -44.9 | -786.0 |
| Tax rate | 292.1% | 12.9% | 13.9% | |
| Net income | -163.5 | -421.0 | -277.3 | 1,584.4 |
| Net margin | -2.8% | -9.4% | -9.3% | 58.7% |
| |
| Diluted EPS | ($0.19) | ($0.53) | ($0.41) | $2.34 |
| Shares outstanding (diluted) | 851.4 | 796.9 | 668.8 | 676.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|